DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: This dystrophinopathy is generally characterized by large deletions of the dystrophin gene that do not alter the coding reading frame of the mRNA and that therefore, results in the expression of a shorter although partially functional dystrophin protein.